Background-Rare mutations of the epithelial sodium channel (ENaC) lead to mendelian forms of salt-sensitive hypertension or salt-wasting hypotension. We aimed to examine the association between common variants in the ENaC genes and salt sensitivity of blood pressure (BP).
I nteractions among numerous genetic and environmental factors play an important role in blood pressure (BP) regulation. High-dietary sodium intake is one of the most important environmental risk factors for elevated BP. [1] [2] [3] However, BP response to dietary sodium intake varies considerably among individuals, a phenomenon known as salt sensitivity. 4, 5 Salt sensitivity of BP has been associated with an increased risk of hypertension, cardiovascular disease, and premature death. 6, 7 Previous studies have suggested that an individual's genetic profile may contribute to their BP responses to dietary sodium intake. 8 -13 Thus, the investigation of genetic determinants of salt sensitivity will help to understand the potential interaction between genetic factors and dietary sodium intake on the regulation of BP.
Clinical Perspective on p 380
The renal epithelial sodium channel (ENaC) mediates net renal reabsorption of sodium in the distal tubule and is critical for the control of sodium balance, blood volume, and thereby of BP. 14, 15 ENaC is composed of 3 partly homologous subunits, ␣, ␤, and ␥. 16 It has been documented that gain-offunction mutations of ENaC genes lead to mendelian forms of hypertension or hypotension. For example, mutations in the cytoplasmic C terminus of either the ␤or ␥-subunit of ENaC cause Liddle syndrome, which is an autosomal dominant form of salt-sensitive hypertension and associated with increased ENaC activity and sodium reabsorption of the kidney. [17] [18] [19] [20] On the other hand, mutations in ENaC subunits may also cause pseudohypoaldosteronism type I, which is an inherited form of severe hypotension and salt wasting. 21 Recently, researchers have tried to identify common variants of ENaC genes that may influence the risk of essential hypertension and reported inconsistent results. [22] [23] [24] [25] Iwai et al 22 reported that single-nucleotide polymorphism (SNP) rs5718, also known as G(Ϫ173)A, in the promoter region of the ENaC ␥-subunit gene was associated with low systolic BP (SBP) in a Japanese population. However, this finding was not replicated in 2 independent studies of white Australians. 23, 26 In addition, 2 studies conducted in Chinese Kazakhs reported inconsistent findings about the association of rs879605 in the ␣-subunit gene with hypertension. 24, 25 These discrepancies might reflect differences in genetic architecture and linkage disequilibrium (LD) patterns among different ethnicities and heterogeneity of hypertension etiology among individuals even within the same ethnicity. Furthermore, none of these studies took into account the gene-sodium interaction on BP. Animal experiments suggested that variants of the ENaC genes and sodium intake might interactively determine the development of hypertension. 27 We examined the association between common variants in ENaC genes and BP responses to dietary sodium intervention in the Genetic Epidemiology Network of Salt Sensitivity (GenSalt) study.
Methods

Study Participants
The GenSalt study was a family-based dietary feeding study conducted in rural areas of northern China from 2003 to 2005. A community-based BP screening was conducted among persons ages 18 to 60 years in the study villages to identify potential probands and their families. The probands who had a mean SBP between 130 to 160 mm Hg and/or a diastolic BP (DBP) between 85 to 100 mm Hg and no use of antihypertensive medications and their spouses, siblings, and offspring were recruited for the dietary feeding study. All participants were of Han Chinese ethnicity. Individuals who had stage-2 hypertension, secondary hypertension, a history of clinical cardiovascular disease or diabetes, used antihypertensive medications, or were pregnant, heavy alcohol drinkers, or currently on a low-sodium diet were excluded from the study. More information about study design and participants has been published elsewhere. 28 Among 1906 eligible participants for the dietary intervention, 1871 (98.2%) and 1860 (97.6%) completed the low-sodium and highsodium interventions, respectively, and were included in the current analysis. Institutional review boards or ethics committees at all participating institutes approved the study protocol. Written informed consent for the baseline observation and for the intervention was obtained from each participant before data collection or intervention, respectively.
Dietary Intervention
After a 3-day baseline observation, the study participants received a 7-day low-sodium diet (3 g of sodium chloride or 51.3 mmol of sodium or 1,179.9 mg of sodium per day) followed by a 7-day high-sodium diet (18 g of sodium chloride or 307.8 mmol of sodium or 7079.4 mg of sodium per day). All foods were cooked without salt, and prepackaged salt was added to the individual study participant's meal when it was served by the study staff. To ensure study participants' compliance to the intervention program, they were required to avoid consuming any foods and beverages that were not provided by the study. Dietary compliance by the participants was confirmed by measurements of 24-hour urinary excretion of sodium and potassium. One 24-hour and 2 overnight urine specimens were collected at the baseline and the last 3 days of each intervention phase. The overnight urinary sodium excretion was converted to 24-hour values through the use of the formulas developed from a random subsample of 238 subjects who collected overnight and 24-hour urine samples on the same days. The mean (standard deviation) of 24-hour urinary excretions of sodium and potassium were 242.4 (66.7) mmol and 36.9 (9.6) mmol at baseline, 47.5 (16.0) mmol, and 31.4 (7.7) mmol during the low-sodium intervention and 244.3 (37.7) mmol and 35.7 (7.5) mmol during the high-sodium intervention, respectively.
BP Measurements
Three sitting BP measurements were obtained each morning of the 3-day baseline observation and on days 5, 6, and 7 of each intervention period by the trained and certified observers, using a random-zero sphygmomanometer according to a standard protocol. 29 BP levels at baseline and during intervention were calculated as the mean of 9 measurements from each period.
Previous GenSalt analysis showed that BP responses to lowsodium and to high-sodium interventions shared some but not all genetic determinants (genetic correlation coefficients ϭϪ0.43, Pϭ0.03 for SBP and ϭϪ0.58, Pϭ0.0003 for DBP). 30 BP response to high-sodium intervention from low-sodium intervention may provide a more valid phenotype measure for salt sensitivity because participants' sodium intake was controlled during both phases. On the other hand, identifying genetic determinants of BP response to low-sodium from usual diet should have more direct clinical and public health implications. Therefore, we used BP responses to low-sodium intervention from baseline and responses to highsodium intervention from low-sodium intervention. In the text and tables, the terms "BP response to low-sodium intervention from baseline" and "BP response to high-sodium intervention from low-sodium intervention" are simplified as "BP response to lowsodium" and "BP response to high-sodium," respectively.
SNP Selection and Genotyping
Both SCNN1B and SCNN1G genes are located on chromosome 16, whereas SCNN1A is located on chromosome 12. Tag SNPs from these genes were selected on the basis of empirical patterns of LD structure in the Chinese Han of Beijing HapMap sample, using Tagger software. The r 2 threshold used for selecting each tagSNP was 0.8. We also included SNPs that were previously reported to be associated with BP or hypertension. SNPs were genotyped with the use of SNPlex assays (Applied Biosystems, Foster City, CA), based on oligonucleotide ligation assay for capillary electrophoresis on ABI 3700 DNA Analyzers (Applied Biosystems). To provide better coverage of these 3 genes, we included additional SNPs genotyped on the Affymetrix 6.0 platform (Affymetrix, Santa Clara, CA), which had minor allele frequencies Ͼ0.01. In total, 46 SNPs passed quality control and were included in this analysis. The detailed information for these SNPs concerning their genome and gene locations, allele frequencies, and probability values for the Hardy-Weinberg equilibrium test is presented in online-only Data Supplement Table SI (please see http://hyper.ahajournal.org).
Statistical Analysis
The mendelian consistency of the SNP genotype data was assessed by PLINK (version 1.05; http://pngu.mgh.harvard.edu/ϳpurcell/ plink/). 31 We used Haploview software (version 4.2; http://www. broadinstitute.org/haploview) to test the Hardy-Weinberg equilib-rium for each SNP and estimate the extent of pairwise LD between SNPs. 32 The solid spine LD method, as implemented in Haploview, was used to define LD blocks.
Baseline characteristics and BP response variables of intervention participants were summarized as means (standard deviations) and medians (ranges) for continuous variables and as percentages for categorical variables. Analyses of the association between SNPs and BP response phenotypes were conducted using a linear mixed-effects model implemented in the Proc Mixed procedure of SAS (version 9.1; SAS Institute, Cary, NC). A "sandwich" option was used to compute the estimated variance-covariance matrix of the fixed-effects (genetic variant effects) parameters by using the asymptotically consistent estimator. Because most of the studied families (random effects) only included sib pairs, we selected compound symmetry as the covariance structure, which assumes the same degree of dependency among family members. Age, sex, BP measurement room temperature, and study site were adjusted in multivariable analyses. Additive genetic models were assumed. The false discovery rate method was used to adjust for multiple testing. 33 A false discovery rate q value is calculated in this method to estimate the proportion of rejected null hypotheses which are erroneously rejected. We used the Proc Mult test procedure, along with the false discovery rate option, in SAS to calculate q value for each SNP. A q value of 0.05 was used as the threshold for statistical significance in our study. Table 1 shows study participants' baseline characteristics, BP levels during low-sodium and high-sodium interventions, and BP responses to dietary sodium interventions. Overall, BP levels decreased from baseline to low-sodium intervention and increased from low-sodium to high-sodium intervention. BP levels were similar at baseline and during the high-sodium intervention. BP responses to dietary sodium intervention were significantly different from zero.
Results
The Figure shows the association of each SNP with SBP and DBP responses to low-sodium and high-sodium interventions. After adjusting for age, sex, BP measurement, room temperature, and study site, multiple SNPs in the SCNN1A, SCNN1B, and SCNN1G genes were associated with BP responses to dietary sodium intervention, with probability values Ͻ0.05. The regression coefficient estimates and standard errors are shown in Table 2 . Several SNPs in the SCNN1A and SCNN1B genes were associated with BP responses to high-sodium intervention, although the statistical significance did not remain after correcting for multiple comparisons. For example, the minor A allele of SNP rs250567 of SCNN1B was associated with 0.95 mm Hg (Pϭ0.004, qϭ0.18) and 0.82 mm Hg (Pϭ0.01, qϭ0.36) decreased SBP and DBP responses to high-sodium intervention, respectively, compared with its major G allele. After adjusting for multiple testing, 6 SNPs from SCNN1G were significantly associated with SBP response to low-sodium intervention. The 4 SNPs with the smallest probability values (rs4073930, rs4073291, rs7404408, and rs5735) were in the same LD block and highly correlated with each other (online-only Data Supplement Figure SI , please see http://circgenetics.ahajournals.org). The minor alleles of these 4 SNPs were associated with a smaller SBP decrease in response to low-sodium intervention. For example, the minor allele G of SNP rs4073291 was associated with 1.33 mm Hg lower SBP reduction during low-sodium intervention (Pϭ1.1ϫ10 Ϫ5 , qϭ3.0ϫ10 Ϫ4 ).
Discussion
Our study identified several common variants in the ENaC genes that may contribute to the BP response to dietary sodium intake. To our knowledge, this is the first report of a comprehensive analysis of association between common variants in the ENaC genes and BP response to dietary sodium intervention.
A previous study in an animal model indicated that ENaC genes might play a critical role in salt-sensitive hypertension. 20 Pradervand et al 27 generated a mouse model of Liddle syndrome with deletion of the C terminus of ENaC ␤-subunit by Cre/loxP-mediated recombination. Under normal sodium diet, mice heterozygous (L/ϩ) and homozygous (L/L) for Liddle mutation (L) develop normally during the first 3 months of life and have BP levels similar to wild-type. Under high sodium intake, the mice with Liddle syndrome mutation have development of high BP, metabolic alkalosis, and hypokalemia accompanied by cardiac and renal hypertrophy.
Multiple mutations in the ENaC ␤and ␥-subunits have been related to Liddle syndrome in humans. Most of them cause the deletion of a conserved proline-rich PY motif (codon 611 to 623) in the cytoplasmic C-terminus region of the ␤or ␥-subunits, resulting in increased ENaC activity. 34 A mutation Asn530Ser of the ␥-subunit, outside of the PY motif, was also reported to be associated with Liddle syndrome. 35 In the single SNP analysis of our study, 6 SNPs of the SCNN1G gene, 1 in an exon and 5 in introns, showed Table 2 ‡FDR q values Ͻ0.05. ␤ is the effect size on BP response (in mm Hg) per minor allele, based on the additive genetic model. Age, sex, BP measurement room temperature, and study site were adjusted in the mixed-effects models. significant association with SBP response to low-sodium intervention. The significant exonic SNP rs5735 is synonymous and does not change the amino acid encoded. A study of a Japanese population and 2 studies of Caucasian populations did not find an association between this synonymous mutation and BP. 22, 26, 36 To speculate on the functional implication of the 5 significant intronic SNPs, we used the Web tool FastSNP, which could analyze potential SNP function using a variety of biological databases and analytic tools. 37 Two of the 5 SNPs, rs4073930 and rs4299163, are possible intronic enhancers for the regulation of gene expression. On the other hand, it is a possibility that none of these SNPs are causal and they are simply in high LD with the true causal variant, which was not tested in the current study. To fully interpret these associations, further dissection of the regions surrounding these SNPs and functional studies are warranted in the future.
. Regression Coefficients (Standard Errors) of BP Responses to Low-Sodium and High-Sodium Interventions Associated With Minor Alleles From Linear Mixed-Effects Models
Investigators have expended much effort to sequence the exons of the SCNN1B gene to find mutations associated with BP in the general population. T594 mol/L is the most studied mutation and has been implicated as a gain-of-function mutation causing impaired renal sodium excretion and salt-sensitive hypertension. 38, 39 However, this mutation appears to be unique for people of African descent and was absent in selected European, American, or Japanese populations. 38, 40 T594M was not genotyped in our study. In addition, some other mutations of the SCNN1B gene were detected in a Japanese population, but none of them was associated with BP levels. 41 Recently, several common variants of SCNN1B were reported to be associated with BP or hypertension in white Europeans (rs239345), Chileans (a GT short tandem repeat in intron 8), and Koreans (rs7205273 and rs8044970). [42] [43] [44] In our study, these SNPs were not significantly associated with salt sensitivity of BP. However, SNP rs250567 of the SCNN1B gene showed a trend toward association with BP response to high-sodium intervention. This SNP is located at the 3Ј flanking region and has no inferred functional implication, based on the analysis by FastSNP. Further resequencing to discover new genetic variants around this SNP may help to detect stronger signals and identify functional variants.
Mutations in the SCNN1A gene could lead to pseudohypoaldosteronism type I. 21 However, we did not observe any associations between common variants of SCNN1A and salt sensitivity of BP after adjusting for multiple testing. Inconsistent results on the association of BP to a common promoter SNP rs879605, also known as G2139A, have been reported across studies. The G2139A allele was associated with higher BP level in a Japanese population. 45 A haplotype containing this allele was found to be associated with essential hypertension in a sample of Kazakhs, a Chinese minority group. 25 However, neither single-marker nor haplotype analysis of this SNP was associated with hypertension in another sample of Chinese Kazakhs. 24 In our study, the association between one of its adjacent SNPs, rs11064153, and salt sensitivity of BP was not significant.
To the best of our knowledge, we report for the first time significant associations between common variants of the ENaC genes and BP response to dietary sodium intervention. These findings suggest that the variants in ENaC genes play an important role in the development of salt-sensitive hypertension. Furthermore, low-sodium intervention might be particularly effective in lowering BP among individuals with specific variants of ENaC genes. Replication of these results in other populations and further functional studies are critically important for identifying true causal variants.
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